-
G288949-5mgSelective EP4receptor competitive antagonist.
-
G287963-10mgGW-803430 may be used in MCHR1-mediated cell signaling studies.
-
G287963-25mgGW-803430 may be used in MCHR1-mediated cell signaling studies.
-
G287963-50mgGW-803430 may be used in MCHR1-mediated cell signaling studies.
-
G287963-5mgGW-803430 may be used in MCHR1-mediated cell signaling studies.
-
G341249-1mgFour G protein-coupled receptors, EP1-4, initiate cellular signaling in response to prostaglandin PGE2. The receptor EP1 acts via Gαq to evoke diverse effects, including renal vasoconstriction, bronchoconstriction, hyperalgesia, allodynia, gastric
-
G341249-500μgFour G protein-coupled receptors, EP1-4, initiate cellular signaling in response to prostaglandin PGE2. The receptor EP1 acts via Gαq to evoke diverse effects, including renal vasoconstriction, bronchoconstriction, hyperalgesia, allodynia, gastric
-
G348055-1mgGW 9578 is a potent agonist of PPARα that activates the murine and human receptors with EC|50|values of 0.005 and 0.05 μM, respectively. GW 9578 is highly selective for PPARα compared to PPARγ and PPARβ. GW 9578 is a potent lipid lowering agent.
-
G348055-500μgGW 9578 is a potent agonist of PPARα that activates the murine and human receptors with EC|50|values of 0.005 and 0.05 μM, respectively. GW 9578 is highly selective for PPARα compared to PPARγ and PPARβ. GW 9578 is a potent lipid lowering agent.
-
-
-